Loading...

Need to buy a college healthcare presentation harvard graduate a4 (british/european)


Cochrane news cochrane uk

ISPOR 20th Annual European Congress 4-8 November 2017 HEALTH CARE USE & POLICY STUDIES RESEARCH ON METHODS STUDIES POSTERS SET-UP: RESEARCH ON METHODS - Clinical Outcomes Methods PRM1 Badrinath K 2Kasturba Medical College, Manipal, Manipal University, Manipal, India PRM2 A2 COULD EMBASE EMTREE INDEX SEARCH TERMS BE FOCUSED TO REDUCE NUMBERS TO SCREEN IN CLINICAL SYSTEMATIC REVIEWS? Cadwell K, Fox D, Jones G PHMR Ltd, London, UK A3 A REAL WORLD EVIDENCE (RWE) APPROACH TO CHARACTERISING AN ULTRA-RARE DISEASE (URD) COHORT OF METASTATIC UVEAL MELANOMA (MUM) PATIENTS WITHIN NATIONAL HEALTH SERVICE ENGLAND (NHSE) Schwenkglenks M 2Health iQ Ltd, London, UK, 3Aquarius Population Health Limited, London, UK, 4Immunocore Limited, Abingdon, UK PRM4 Kim H 3 2Chung-Ang University College of Pharmacy, Seoul, Korea, Republic of (South), 3Evidence-Based Research and Clinical Research Lab., Department of Health, Social and Clinical Pharmacy, College of Pharmacy, Chung-Ang University, Seoul, Korea, Republic of (South) PRM5 Jansen J 1, Garssen J 2Nutricia Research, Utrecht, The Netherlands, 3Swinburne University, Melbourne, Australia, 4University of Edinburgh, Edinburgh, UK PRM6 A6 USING CONVERGENT MIXED METHODS TO EVALUATE TREATMENT RISKS AND BENEFITS IN RARE DISEASE: AN EXAMPLE FROM A PHASE II REGISTRATION TRIAL IN METASTATIC MERKEL CELL CARCINOMA Bharmal M 2Mapi, Patient-Centered Outcomes, Lyon, France, 3EMD Serono, Billerica, MA, USA PRM7 Hopkinson D 2Incyte Corporation, Wilmington, DE, USA PRM8 A8 ANALYSIS OF EFFECTIVENESS CRITERIA IN PHARMACOECONOMIC STUDIES OF ANTIMICROBIAL THERAPEUTIC AGENTS PROPOSED FOR INCLUSION IN THE ESSENTIAL DRUG LIST (RUSSIA) IN 2014-2016.

Kolbin A, Gomon Y PRM9 Hopkinson D 2Incyte Corporation, Wilmington, DE, USA PRM10 A10 IMPACT OF DRUG RELATED PROBLEMS ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HYPERTENSION IN INDONESIAN PRIMARY HEALTH CARE Rahmawati F, Andayani TM, Wijayanti L, Lefiani L Universitas Gadjah Mada, Yogyakarta, Indonesia PRM11 Abbas M 2Jiangsu Cancer Hospital, Nanjing, China PRM12 Lipton RB 2University of Sheffield, Sheffield, UK, 3University of York, Heslington, York, UK, 4Precision Health Economics, Los Angeles, CA, USA, 5BresMed Health Solutions, Sheffield, UK, 6Amgen (Europe) GmbH, Zug, Switzerland, 7Amgen Inc, Thousand Oaks, CA, USA PRM13 Exuzides A 2Bayer AG, Berlin, Germany PRM14 Kloc K 3Institut Gustave Roussy, Villejuif, France, 4Creativ-Ceutical, Paris, France, PRM15 Kloc K 3Institut Gustave Roussy, Villejuif, France, 4Creativ-Ceutical, Paris, France, PRM16 Briceno V 2Hospital Metropolitano, Quito, Ecuador PRM17 Karpati T 2Eli Lilly and Company, Sydney, Australia, 3Eli Lilly and Company, Indianapolis, IN, USA, 4Hadassah Medical Organization, Jerusalem, Israel, 5Eli Lilly and Company, Israel, Ra’anana, Israel, 6Clalit Research Institute, Tel Aviv, Israel PRM18 Smith L 2ICON Clinical Research, Dublin, Ireland, 3ICON Clinical Research, Marlow, UK PRM19 A19 PARAMETRIC MODELLING OF MIGRAINE DAY FREQUENCY IN MIGRAINE PREVENTION: A CASE STUDY OF ERENUMAB CLINICAL TRIAL DATA Porter JK 2University of Sheffield, Sheffield, UK, 3University of York, Heslington, York, UK, 4Albert Einstein College of Medicine, Bronx, NY, USA, 5Precision Health Economics, Los Angeles, CA, USA, 6Amgen Inc, Thousand Oaks, CA, USA PRM20 Ouwens MJ A21 AN ALGORITHM TO QUANTTTATIVELY ESTIMATE EXTRAPOLATED LIFETIME SURVIVAL CURVES FOR ECONOMIC EVALUATION (EE) OF CANCER TREATMENTS WHEN ONLY AGGREGATED PATIENT DATA ARE AVAILABLE; WITH APPLICATION TO METASTATIC PANCREATIC CANCER Gharaibeh M, Alsaid N, Abraham I Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona (Tucson, AZ, USA), Tucson, AZ, USA PRM22 A22 INCLUSION OF COMPARATOR SINGLE ARM TRIALS USED FOR EMA/FDA REGISTRATION IN THE NETWORK META-ANALYSIS USING MATCHING ADJUSTED INDIRECT COMPARISONS Ouwens MJ Deticek A, Mardetko N, Kos M, Locatelli I University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia PRM24 A24 A VALIDATION STUDY OF THE RANK-PRESERVING STRUCTURAL FAILURE TIME MODEL: CONFIDENCE INTERVALS, UNIQUE, MULTIPLE AND ERRONEOUS SOLUTIONS Ouwens MJ 3Registercentrum v stra g taland, G teborg, Sweden PRM25 Simon A, Hapfelmeier J PRM26 A26 AN ANALYSIS OF TRANSLATION CHALLENGES WHEN ADAPTING THE PICTURE NAMING SUBTEST OF THE REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS (RBANS) FOR USE IN MULTINATIONAL STUDIES Bartolic E 2TransPerfect, London, UK, 4TransPerfect, New York, NY, USA, 5TransPerfect, San Francisco, CA, USA PRM27 Krieger T PRM28 B1 USING AN INSTRUMENTAL VARIABLE APPROACH TO ESTIMATE CAUSAL TREATMENT EFFECTS IN AN OBSERVATIONAL COHORT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE John E, Abrams KR, Sheehan N, Brightling C University of Leicester, Leicester, UK PRM29 B2 USING ELECTRONIC HEALTH RECORDS AS A REAL WORLD COMPARATOR: A CASE STUDY IN A SINGLE ARM ONCOLOGY TRIAL Davies J 2F Private equity is notoriously picky about educational backgrounds, are will usually target graduates from top universities. In Europe, there is a strong representation from schools such as Oxford/Cambridge in the UK, HEC/Essec in France, etc. The reasons are that they have a large choice of applicants so the school is an  .Kolbin A, Gomon Y PRM9 Hopkinson D 2Incyte Corporation, Wilmington, DE, USA PRM10 A10 IMPACT OF DRUG RELATED PROBLEMS ON BLOOD PRESSURE CONTROL IN PATIENTS WITH HYPERTENSION IN INDONESIAN PRIMARY HEALTH CARE Rahmawati F, Andayani TM, Wijayanti L, Lefiani L Universitas Gadjah Mada, Yogyakarta, Indonesia PRM11 Abbas M 2Jiangsu Cancer Hospital, Nanjing, China PRM12 Lipton RB 2University of Sheffield, Sheffield, UK, 3University of York, Heslington, York, UK, 4Precision Health Economics, Los Angeles, CA, USA, 5BresMed Health Solutions, Sheffield, UK, 6Amgen (Europe) GmbH, Zug, Switzerland, 7Amgen Inc, Thousand Oaks, CA, USA PRM13 Exuzides A 2Bayer AG, Berlin, Germany PRM14 Kloc K 3Institut Gustave Roussy, Villejuif, France, 4Creativ-Ceutical, Paris, France, PRM15 Kloc K 3Institut Gustave Roussy, Villejuif, France, 4Creativ-Ceutical, Paris, France, PRM16 Briceno V 2Hospital Metropolitano, Quito, Ecuador PRM17 Karpati T 2Eli Lilly and Company, Sydney, Australia, 3Eli Lilly and Company, Indianapolis, IN, USA, 4Hadassah Medical Organization, Jerusalem, Israel, 5Eli Lilly and Company, Israel, Ra’anana, Israel, 6Clalit Research Institute, Tel Aviv, Israel PRM18 Smith L 2ICON Clinical Research, Dublin, Ireland, 3ICON Clinical Research, Marlow, UK PRM19 A19 PARAMETRIC MODELLING OF MIGRAINE DAY FREQUENCY IN MIGRAINE PREVENTION: A CASE STUDY OF ERENUMAB CLINICAL TRIAL DATA Porter JK 2University of Sheffield, Sheffield, UK, 3University of York, Heslington, York, UK, 4Albert Einstein College of Medicine, Bronx, NY, USA, 5Precision Health Economics, Los Angeles, CA, USA, 6Amgen Inc, Thousand Oaks, CA, USA PRM20 Ouwens MJ A21 AN ALGORITHM TO QUANTTTATIVELY ESTIMATE EXTRAPOLATED LIFETIME SURVIVAL CURVES FOR ECONOMIC EVALUATION (EE) OF CANCER TREATMENTS WHEN ONLY AGGREGATED PATIENT DATA ARE AVAILABLE; WITH APPLICATION TO METASTATIC PANCREATIC CANCER Gharaibeh M, Alsaid N, Abraham I Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona (Tucson, AZ, USA), Tucson, AZ, USA PRM22 A22 INCLUSION OF COMPARATOR SINGLE ARM TRIALS USED FOR EMA/FDA REGISTRATION IN THE NETWORK META-ANALYSIS USING MATCHING ADJUSTED INDIRECT COMPARISONS Ouwens MJ Deticek A, Mardetko N, Kos M, Locatelli I University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia PRM24 A24 A VALIDATION STUDY OF THE RANK-PRESERVING STRUCTURAL FAILURE TIME MODEL: CONFIDENCE INTERVALS, UNIQUE, MULTIPLE AND ERRONEOUS SOLUTIONS Ouwens MJ 3Registercentrum v stra g taland, G teborg, Sweden PRM25 Simon A, Hapfelmeier J PRM26 A26 AN ANALYSIS OF TRANSLATION CHALLENGES WHEN ADAPTING THE PICTURE NAMING SUBTEST OF THE REPEATABLE BATTERY FOR THE ASSESSMENT OF NEUROPSYCHOLOGICAL STATUS (RBANS) FOR USE IN MULTINATIONAL STUDIES Bartolic E 2TransPerfect, London, UK, 4TransPerfect, New York, NY, USA, 5TransPerfect, San Francisco, CA, USA PRM27 Krieger T PRM28 B1 USING AN INSTRUMENTAL VARIABLE APPROACH TO ESTIMATE CAUSAL TREATMENT EFFECTS IN AN OBSERVATIONAL COHORT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE John E, Abrams KR, Sheehan N, Brightling C University of Leicester, Leicester, UK PRM29 B2 USING ELECTRONIC HEALTH RECORDS AS A REAL WORLD COMPARATOR: A CASE STUDY IN A SINGLE ARM ONCOLOGY TRIAL Davies J 2F.

Hoffmann-La Roche Ltd, Basel, Switzerland, 3Roche (RWD), Welwyn Garden City, UK, 4Roche S., Boulogne-Billancourt cedex, France, 5Roche Pharma AG, Grenzach-Wyhlen, Germany, 6University of Liverpool, Liverpool, UK PRM30 B3 CONCEPTUALIZATION, DEVELOPMENT, AND INTERNAL AND EXTERNAL VALIDATION OF A ‘WHOLE DISEASE’ MODEL FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE Ghanbarian S, Sin D, Adibi A, FitzGerald JM, Bryan S, Sadatsafavi M University of British Columbia, Vancouver, BC, Canada RESEARCH ON METHODS - Cost Methods PRM31 B4 COMPARING COSTS AND OUTCOMES BETWEEN COBLATION TECHNOLOGY AND MECHANICAL DEBRIDEMENT IN THE TREATMENT OF KNEE CARTILAGE LESIONS- A COST-EFFECTIVENESS ANALYSIS FROM A US PAYER PERSPECTIVE Adeyemi A 2Smith & Nephew, Hull, UK, 3Smith & Nephew, Fort Worth, TX, USA PRM32 Messaoudi S, PRM33 B6 Hern ndez R 2Newcastle University, Newcastle upon Tyne, UK, 3University of St andrews, St Andrews, Fife, UK PRM34 B7 COST –EFFECTIVENESS OF OBINUTUZUMAB AS FRONTLINE TREATMENT FOR UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA IN REPUBLIC OF MACEDONIA Kapedanovska Nestorovska A, Sterjev Z, Naumovska Z, Grozdanova A, Dimovski A, Suturkova L ISPOR Republic of Macedonia regional chapter, Skopje, Macedonia PRM35 Hidalgo A 2University of Castilla-La Mancha, Talavera de la Reina, Spain PRM36 Naumovska Z 2ISPOR Republic of Macedonia regional chapter, Skopje, Macedonia, 3Faculty of Pharmacy, UKIM-Skopje, Skopje, Macedonia PRM37 Tanaka GK 2FEDERAL UNIVERSITY OF PARAN , CURITIBA , PARAN , BRAZIL, Brazil, 3UNIVERSIDADE FEDERAL DO PARAN , CURITIBA , PARAN , Brazil, 4ICS, CURITIBA , PARAN , BRAZIL, Brazil PRM38 Khan RA 2Poona College of Pharmacy, Bharati Vidyapeeth Deemed University, Pune, India PRM39 Moorkens E 2The Erasmus University Medical Center, Rotterdam, The Netherlands PRM40 Cima J, Guimar es P, Almeida AS Faculdade de Economia, Universidade do Porto, Porto, Portugal PRM41 B14 HEALTH INSURANCE PERSPECTIVE AND COLLECTIVE PERSPECTIVE: THE DIFFERENCES IN THE COLLECTION AND VALUATION OF COST DATA IN FRANCE Carette J, Roze S, Petitjean A, Gherardi A PRM42 B15 A UNIFORM PROBABILISTIC APPROACH TO MANAGE UNCERTAINTIES REGARDING VACCINE EFFECTIVENESS AGAINST SEROTYPE 3, 19A, NTHI AND HERD EFFECT IN THE BASE CASE OF A COST-EFFECTIVENESS ANALYSIS COMPARING NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D (PHID-CV) WITH 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINES (PCV13) IN INFANTS Olbrecht J PRM43 Tomek D 2Ministry of Health of the Slovak Republic, Bratislava, Slovakia, 3Slovak Society of Pharmacoeconomics, Bratislava, Slovakia PRM44 McManus E 2 2University of Nottingham, Nottingham, UK PRM45 B18 IDENTIFYING COST EFFECTIVE METHODS OF HEALTH TECHNOLOGY ASSESSMENT FOR DEVELOPERS – THE NEED FOR FAST AND FRUGAL EVALUATION Bouttell J 2University of Glasgow, Glasgow, UK PRM46 B19 WHICH INFORMATION SOURCES SHOULD BE USED TO IDENTIFY STUDIES FOR SYSTEMATIC REVIEWS OF ECONOMIC EVALUATIONS IN HEALTHCARE? Arber M, Wood H, Isojarvi J, Glanville J York Health Economics Consortium, York, UK PRM47 B20 SINGLE DISTRIBUTION, TWO-PART, AND TWO-COMPONENT FINITE MIXTURE MODELS FOR PREDICTING SMOKING-RELATED INDIRECT COSTS IN US WORKING ADULTS Li VW 2Kantar Health, New York, NY, USA, 3Pfizer Inc.

, New York, NY, USA PRM48 Wright SJ, Moore H, Daker-White G, Newman W, Payne K The University of Manchester, Manchester, UK PRM49 Zhou J 2Creativ-Ceutical, Paris, France B23 COST-EFFECTIVENESS ANALYSIS OF CHIDAMIDE VERSUS CHEMOTHERAPY ON THE TREATMENT OF PERIPHERAL T - CELL LYMPHOMA PATIENTS IN CHINA Ma J 1Harbin Institute of Hematology and Oncology, Harbin, China, 2Department of Medical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China, 3Lymphoma division,Beijing Cancer Hospital, Beijing, China, 4Cancer prevention and treatment center of Zhongshan University, guangzhou, China, 5Jiangsu Province Hospital, nanjing, China, 6Ruijin Hospital,Shanghai Jiaotong University School of Medicine, shanghai, China, 7Shenzhen Chipscreen Bioscience Ltd, shenzhen, China, 8Shanghai Centennial Scientific Ltd, Shanghai, China, 9Institute of Pharmaceutical Economics, Sun Yat - sen University, guangzhou, China PRM51 Geenen JW, Belitser SV, Vreman RA, Klungel O, Raaijmakers JA, Hovels A Utrecht University, Utrecht, The Netherlands PRM52 Zhou J 2Creativ-Ceutical, Paris, France B26 THE IMPACT OF THE LEARNING CURVE ON COSTS AND EFFECTS OF NOVEL MEDICAL DEVICES.EVIDENCE FROM REGISTRY DATA Federici C, Armeni P, Costa F, Tarricone R SDA Bocconi School of Management, Milan, Italy PRM54 B27 MONTECARLO MODEL AS A TOOL IN ESTIMATION OF ECONOMIC BURDEN OF A DISEASE THROUGH THE PREDICTION OF BIOLOGICAL CHARACTERISTICS OF TUMOR IN BREAST CANCER Balderas-Pe a L 2Universidad de Guadalajara.Centro Universitario de Ciencias de la Salud, Guadalajara, Jalisco, Mexico, 3Hospital General de Zona No.Francisco Padr n Puyou", San Luis Potos , SLP, Mexico, 4UMAE Hospital de Gineco-Obstetricia Centro M dico Nacional de Occidente IMSS, Guadalajara, Jalisco, Mexico, 5Unidad M dica de Alta Especialidad Hospital de Especialidades.

Centro M dico Nacional de Occidente, Guadalajara, Jalisco, Mexico PRM55 C1 MODELING TECHNIQUES FOR FITTING HEALTHCARE RESOURCE USE COSTS DERIVED FROM PATIENT REPORTED COUNTS OF HOSPITAL, ER, AND PCP VISITS Liebert R, Sanders A, Kudel I Kantar Health, New York, NY, USA PRM56 C2 Sach TH 2Norfolk and Norwich University Hospital, Norwich, UK, 3University of Nottingham, Nottingham, UK PRM57 C3 CLASSIFICATION OF CAUSES OF HOSPITALIZATION FOR HEART FAILURE PATIENTS IN COST-EFFECTIVENESS AND COST-UTILITY EVALUATIONS OF PHARMACOTHERAPEUTIC, SURGICAL, AND MANAGED-CARE INTERVENTIONS: SYSTEMATIC REVIEW Alsaid N 1 1Center for Health Outcomes and PharmacoEconomic Research, College of Pharmacy, University of Arizona (Tucson, AZ, USA), Tucson, AZ, USA, 2Sarver Heart Center, University of Arizona (Tucson, AZ, USA), Tucson, AZ, USA, 3College of Medicine, University of Arizona (Phoenix, AZ.USA), Phoenix, AZ, USA, 4Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona (Tucson, AZ, USA), Tucson, AZ, USA PRM58 Dijk HH, Freriks RD, Mierau JO University of Groningen, Groningen, The Netherlands RESEARCH ON METHODS - Databases & Management Methods PRM59 C5 CONVERSION OF A FRENCH ELECTRONIC MEDICAL RECORD (EMR) DATABASE INTO THE OBSERVATIONAL MEDICAL OUTCOMES PARTNERSHIP COMMON DATA MODEL.Schwalm M 2QuintilesIMS, Philadelphia, PA, USA, 3QuintilesIMS, Parsippany, NJ, USA, 4QuintilesIMS, Warren, NJ, USA, 5QuintilesIMS, San Francisco, CA, USA PRM60 Bergot E 2HEVA, LYON, France, PRM61 Augustynska J, Skora K, Walczak J, Tomassy J Arcana Institute Ltd, Krakow, Poland PRM62 Simeone J 2Merck, North Wales, PA, USA PRM63 C9 INSIGHT INTO THE ROLE OF THE GENERAL PRACTITIONER IN THE MANAGEMENT OF COLORECTAL CANCER: RECORD LINKAGE OF THE NETHERLANDS CANCER REGISTRY AND THE GENERAL PRACTITIONER DATABASE OF THE PHARMO DATABASE NETWORK Kuiper JG 2University Medical Center Utrecht, Utrecht, The Netherlands, 3Netherlands Comprehensive Cancer Organisation, Eindhoven, The Netherlands, 4STIZON, Utrecht, The Netherlands, 5PHARMO Institute for Drug Outcomes Research, Utrecht, The Netherlands PRM64 C10 Sammon C, Glover M Arnould B 2Janssen Global Services, LLC, Raritan, NJ, USA, 3Mapi Research Trust, Lyon, France, 4Mapi, Lyon, France Vertuani S 2Mapi Group, Stockholm, Sweden PRM67 Vlamynck G, Pau D, Magrez D, veleno-Salotti A Roche, Boulogne-Billancourt, France Menditto E 2Royal College of Surgeons in Ireland, Dublin, Ireland, 3Aragon Health Service (SALUD), Zaragoza, Spain, 4Aragon Health Sciences Institute (IACS).IIS Arag n, REDISSEC ISCIII, Zaragoza, Spain, 5University of Zaragoza, Zaragoza, Spain, 6Department of Family Medicine, Medical University of Lodz, Lodz, Poland PRM69 Durand-Zaleski I 2Bristol-Myers Squibb, Rueil-Malmaison, France, 3The Netherlands Cancer Institute, Amsterdam, The Netherlands, 4Bristol-Myers Squibb, Madrid, Spain, 5The Royal Free Hospital, London, UK, 6Centre Hospitalier Intercommunal, DHU-ATVB, D partement de Pneumologie et Pathologie Professionnelle, Cr teil, France, 7Karolinska University Hospital, Stockholm, Sweden, 8QuintilesIMS, London, UK, 10Bristol-Myers Squibb, Mexico City, Mexico, 11Irish Cancer Society, Dublin, Ireland, 12Bristol-Myers Squibb Co., Princeton, NJ, USA, 13Bristol-Myers Squibb, Princeton, NJ, USA, 14Bristol-Myers Squibb, Uxbridge, UK, 15Aarhus University Hospital, Aarhus, Denmark PRM70 Schmid K, Hapfelmeier J PRM71 C17 Leleu H 2Janssen-Cilag B.

, Breda, The Netherlands, 3SMS-Oncology BV, Amsterdam, The Netherlands, 4Janssen-Cilag, Issy-les-Moulineaux, France C18 Doly A 3Institut Curie, Paris, France, 4Centre hospitalier Ren Dubos, Cergy Pontoise, France, 5Ramsay G n rale de Sant , H pital Priv Drome Ard che, Valence, France, 6Centre L on B rard, Lyon, France, 7GHR Mulhouse et Sud Alsace, Mulhouse, France, 8Institut du Cancer de Montpellier, Montpellier, France, 9CHRU Jean Minjoz, Besan on, France, 10Roche France, Boulogne Billancourt, France, 11, Levallois, France, McDonald L 2Bristol-Myers Squibb, Lawrence Township, NJ, USA PRM74 Vlamynck G PRM75 Risson V 2QuintilesIMS, London, UK, PRM76 C22 ADJUSTING FOR SELECTION BIAS IN EVALUATING TWO-DOSE HUMAN PAPILLOMAVIRUS VACCINE COVERAGE AMONG ADOLESCENTS IN THE UNITED STATES Kurosky S, Trantham L PRM77 Ladron de Guevara P, Patel P Global Pricing Innovations, London, UK PRM78 Wang L 2Iowa State University, Ames, IA, USA, 3UCLA Health, Los Angeles, CA, USA, 4Columbia University and STATinMED Research, New York, NY, USA PRM79 C25 GUIDANCE FOR DEVELOPING A STUDY PROTOCOL OF A CAUSAL COMPARATIVE EFFECTIVENESS ANALYSIS IN “BIG DATA”: THE CASE OF WHEN TO START STATIN TREATMENT Kuehne F 4 1Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i., Austria, 2DEXHELPP, Vienna, Austria, 3dwh GmbH, simulation services / Technical University, Institute for Analysis and Scientific Computing, Vienna, Austria, 4UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.Department of Health Policy and Management, Harvard T.Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA PRM80 C26 REAL WORLD EVIDENCE IN GLAUCOMATOUS DISEASES: EMR DATA IS INDISPENSIBLE FOR UNDERSTANDING PATIENT JOURNEYS AND OPTIMIZING CARE Spera C 2QuintilesIMS, Frankfurt, Germany, PRM81 C27 Jacob C, Guenther J, Borchert K, Krinke K, Braun S Xcenda GmbH, Hannover, Germany Levine CA 2AplusA Research, LYON, France RESEARCH ON METHODS - Modeling Methods PRM83 Conrads-Frank A 1UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i.

, Austria, 2Department of Public Health, Health Services Research and Health Technology Assessment, UMIT - University for Health Sciences, Medical Informatics and Technology, Hall i., Austria, 3UMIT - University for Health Sciences, Medical Informatics and Technology / Institute of Public Health, Medical Decision Making and Health Technology Assessment, Hall i., Austria, 4Technical University, Institute for Analysis and Scientific Computing, Vienna, Austria, 5DEXHELPP, Vienna, Austria, 7Main Association of Austrian Social Insurance Institutions, Vienna, Austria, 8dwh GmbH, simulation services / Technical University, Institute for Analysis and Scientific Computing, Vienna, Austria, 9UMIT, Dept.of Public Health, Health Services Research & HTA / Harvard Univ.Health Policy & Management, Institute for Technology Assessment, Boston, MA / Hall i., Austria PRM84 D3 HOW CAN MIDDLE-INCOME COUNTRIES GET A VALID ESTIMATE OF COST-EFFECTIVENESS OF A DRUG MORE EFFICIENTLY AND EFFECTIVELY? Ansaripour A 2Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands PRM85 Doyle OM, Jayanti H, Homola D, Rigg J QuintilesIMS, London, UK Wen Y 2Academia Sinica, Taipei, Taiwan, 3Chang Gung Memorial Hospital, Taoyuan, Taiwan PRM87 Soikkeli F 2Ingress Health, Rotterdam, The Netherlands, 3University of Groningen, Groningen, The Netherlands PRM88 Hatswell AJ 2University of Alberta, Edmonton, AB, Canada, 3University of Sheffield, Sheffield, UK PRM89 Sadler S 2Exeter University, Exeter, UK PRM90 Husain F, Sayre T, Feinman T, Fazeli MS, Kuang Y, del Aguila MA PRM91 D10 DETERMINANTS OF THE RELATIONSHIP BETWEEN IMPROVED GLUCOSE CONTROL AND MODELED HEALTH OUTCOMES IN TYPE 2 DIABETES SIMULATION MODELS Foos V PRM92 Nemeth B 2Gedeon Richter Plc., Budapest, Hungary, 3E tv s Lor nd University (ELTE), Budapest, Hungary PRM93 McEwan P 2Novo Nordisk Region Europe Pharmaceuticals A/S, Gatwick, UK PRM94 D13 THE POTENTIAL VALUE OF REAL-WORLD EVIDENCE ALONG WITH TRIAL EFFICACY TO ESTIMATE EFFECTIVENESS OF NOVEL TREATMENTS IN REAL-WORLD SETTING; AN APPLICATION WITH OVERALL SURVIVAL IN TWO ONCOLOGY INDICATIONS Soikkeli F 2Ingress-Health HWM GmbH, Wismar, Germany, 3INGRESS-Health HWM GmbH, Wismar, Germany PRM95 D14 THE RELATIONSHIP OF PREDICTED BENEFITS IN LIFE EXPECTANCY AND QUALITY ADJUSTED LIFE EXPECTANCY FOR IMPROVED GLUCOSE CONTROL IN TYPE 2 DIABETES SIMULATION MODELING Ramos M PRM96 D15 SURVIVAL OUTCOMES PREDICTED BY A DISCRETE EVENT SIMULATION MODEL FOR RENAL CELL CARCINOMA FOR USE IN A COST EFFECTIVENESS ANALYSIS: A COMPARISON WITH A TRADITIONAL PARTITIONED SURVIVAL MODEL Treharne C 2PAREXEL, Stockholm, Sweden, PRM97 D16 NEW MODELLING APPROACHES IN OPHTHALMOLOGY: PARTITIONED VISION DISTRBUTION MODEL IN SYMPTOMATIC VITREOMACULAR ADHESION (VMA)/VITREOMACULAR TRACTION (VMT) WITH OR WITHOUT FULL-THICKNESS MACULAR HOLE (FTMH) Bennison C 2Pharmerit International, Berlin, Germany, 3Retina Consultants of Arizona; USC Roski Eye Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA, 4Wills Eye Hospital, Philadelphia, PA, USA, 5Sierra Eye Associates, Reno, NV, USA, 6Wagner Macula and Retina Center, Eastern Virginia Medical School, Virginia Beach, VA, USA, 7Xintera Ltd, Cambridge, UK PRM98 D17 DECISION ANALYTIC MODELLING METHODS FOR THE ASSESSING THE EFFECTIVENESS OF TREATMENT SEQUENCES FOR CLINICAL AND ECONOMIC DECISION MAKING: A METHODOLOGICAL REVIEW Lewis RA, Hughes DA, Wilkinson C Bangor University, Bangor, UK D18 IMPLEMENTATION OF A DATA MINING MODEL WITHIN A MONITORING WEB-BASED TOOL TO ASSESS HER2 BREAST CANCER STATUS USING THE HER-FRANCE REAL WORLD DATABASE Vaul on T 2Roche, Boulogne-Billancourt, France, 4AFAQAP and Hospital of Strasbourg, Strasbourg, France PRM100 Dansk V 3Bristol-Myers Squibb, Uxbridge, UK PRM101 D20 EXPLORATION OF RUN-TIME REQUIREMENTS IN PROBABILISTIC SENSITIVITY ANALYSIS UTILIZING A PATIENT LEVEL BASED TYPE 2 DIABETES SIMULATION MODEL Foos V PRM102 Janzic A, Locatelli I PRM103 Oguz M, Lanitis T D24 A MARKOV MICROSIMULATION MODEL FOR THE ECONOMIC EVALUATION OF PARTIALLY IMPLANTABLE ACTIVE MIDDLE EAR IMPLANTS IN SENSORINEURAL HEARING LOSS Kluibenschaedl M, Kosaner Kliess M, Urban M MED-EL Medical Electronics, Innsbruck, Austria PRM106 D25 REVIEW OF MODELS SUBMITTED TO NICE MEDICAL TECHNOLOGIES EVALUATION PROGRAMME TO INFORM A COST CONSEQUENCE TEMPLATE FOR USE IN MEDICAL TECHNOLOGIES GUIDANCE SUBMISSIONS Eaton Turner E 2National Institute for Health and Care Excellence, Manchester, UK PRM107 van Oostrum I 2University of Groningen, Groningen, The Netherlands, 3University Medical Center Groningen, Groningen, The Netherlands, 4Ingress-health Netherlands, Rotterdam, The Netherlands PRM108 D27 METHODOLOGICAL ANALYSES OF BUDGET IMPACT MODELS SUBMITTED TO THE HAUTE AUTORIT DE SANT (HAS) (FRENCH NATIONAL AUTHORITY FOR HEALTH) Monnier R, Cartier-Bechu C, Gherardi A, Roze S HEVA HEOR Sarl, Lyon, France PRM109 Moln r A 2National Kor nyi Institute for Pulmonology, Budapest, Hungary, 3Kaposv r University Health Center, Kaposv r, Hungary, 4Somogy County Kaposi M r Teaching Hospital, Kaposv r, Hungary, 5Syreon Research Institute, Budapest, Hungary PRM111 Viriato D 2Novartis Pharma AG, Basel, Switzerland, 3Novartis Healthcare Pvt., Hyderabad, India PRM112 Incerti D 2University of Alabama at Birmingham, Birmingham, AL, USA, 3Precision Xtract, Oakland, CA, USA PRM113 Pouwels XG, Joore MA, Ramaekers BL Maastricht University Medical Center+, Maastricht, The Netherlands PRM114 Carey N, Fogarty E, Bryan E, Tilson L National Centre for Pharmacoeconomics, Dublin, Ireland PRM115 E7 ECONOMIC EVALUATION OF A BRIEF COUNSELLING FOR SMOKING CESSATION IN DENTISTRY – A CASE STUDY COMPARING TWO HEALTH ECONOMIC MODELS Feldman I 2Karolinska Institutet, Stockholm, Sweden, 3Public Health & Economics, Huddinge, Sweden PRM116 Teljeur C 2Health Information and Quality Authority, Dublin 7, Ireland, 3Health Information and Quality Authority (HIQA), Dublin, Ireland PRM117 E9 Donten A 2University of Edinburgh, Edinburgh, UK PRM118 Hearmon NC 2Costello Medical Consulting Ltd., London, UK PRM119 E11 ISSUES ENCOUNTERED WHEN MODELLING THE LONG TERM CLINICAL EFFECTIVENESS OF TREATMENTS FROM SHORT TERM TRIALS USING SECOND-LINE TREATMENTS FOR ADVANCED OR METASTATIC RENAL CELL CARCINOMA (AMRCC) AS AN EXAMPLE Edwards SJ, Wakefield V, Cain P, Karner C, Kew K, Bacelar M, Masento N, Salih F BMJ, London, UK E12 EVALUATING THE IMPORTANCE OF REALISTICALLY SIMULATING RISK FACTOR PROGRESSION OVER TIME: A HEALTH ECONOMIC MODELING ANALYSIS IN TYPE 1 DIABETES Pollock RF, Hunt B, PRM121 E13 HOW TO ADDRESS FRENCH HEALTH AUTHORITY (HAS/CEESP) SPECIFIC REQUIREMENTS IN MODELLING RELAPSING-REMITTING MULTIPLE SCLEROSIS IN HEALTH-ECONOMIC EVALUATION? MODELLING TREATMENT SEQUENCES Cartier-Bechu C 2Roche, Boulogne-Billancourt, France E14 A COMPARISON OF MARKOV COHORT AND DISCRETE EVENT SIMULATION MODELS IN COST-EFFECTIVENESS ANALYSIS OF SORAFENIB AND EVEROLIMUS IN 3RD LINE METASTATIC RENAL-CELL CARCINOMA IN THE CZECH REPUBLIC Mlcoch T, Lamblova K, Ornstova E, Dolezal T Value Outcomes, Prague, Czech Republic PRM123 Yi Y, Lucherini S, Bellanca L, Heron L PRM124 E16 WEB APP ESTIMATING COST SAVINGS AND CLINICAL OUTCOMES OF BLOOD GLUCOSE MONITORING PROGRAM.

EXAMPLE FROM THE UK Topachevskyi O 2Digital Health Outcomes, Kiev, Ukraine PRM126 Plumpton CO 2University of Liverpool, Liverpool, UK PRM127 Oguz M, Roiz J E19 COST-EFFECTIVENESS ANALYSIS OF 10% INTRAVENOUS IMMUNOGLOBULIN COMPARED WITH PLASMA EXCHANGE IN TREATMENT OF CHILDREN WITH GUILLAIN–BARR SYNDROME IN RUSSIA Ugrekhelidze D, Yagudina R, Kulikov A I.Sechenov First Moscow State Medical University, Moscow, Russia PRM129 Maruszczak M 2Amgen, Zug, Switzerland Standaert B 3Aix Marseille University Department of Public Health, Marseille, France PRM131 E22 QUANTITY AND QUALITY OF EXTERNAL EVENT VALIDATION PROCEDURES PERFORMED IN PUBLISHED HEALTH ECONOMIC MODELS IN OBESITY: OUTCOMES OF A SYSTEMATIC REVIEW Schwander B 2A2M, Amsterdam, The Netherlands, 3Maastricht University, Maastricht, The Netherlands PRM132 Stephens TJ, Selya-Hammer C, Gauthier A Amaris, London, UK Gal P 2Evidera Inc., London, UK PRM134 E25 COST-EFFECTIVENESS ANALYSIS OF VENETOCLAX FOR TREATMENT OF REFRACTORY/RELAPSED CHRONIC LYMPHOCYTIC LEUKEMIA WITH OR WITHOUT 17P DELETION IN BULGARIA Djambazov S, Veleva N, Tsanova D, Vekov T Medical University Pleven, Pleven, Bulgaria PRM135 McMeekin N, Briggs A, Wu O University of Glasgow, Glasgow, UK PRM136 Paladio-Hern ndez J 2BIOPHARMEX, Mexico City, Mexico PRM137 Shi A 2Universidad San Ignacio de Loyola and University of the Pacific in Lima, Lima, Peru PRM138 Bilbao A 8 1Research Unit, Basurto University Hospital (Osakidetza) – Health Service Research Network on Chronic Diseases (REDISSEC), Bilbao, Spain, 2Villamanta Centre, Navalcarnero Health Centre, Madrid Health Service – REDISSEC, Madrid, Spain, 3Fundaci n Canaria de Investigaci n Sanitaria (FUNCANIS) – REDISSEC, Tenerife, Spain, 4Traumatology and Orthopedic Surgery Service, Basurto University Hospital (Osakidetza) – REDISSEC, Bilbao, Spain, 5Traumatology and Orthopedic Surgery Service, Galdakao-Usansolo Hospital (Osakidetza), Galdakao, Spain, 6Family and Community Care Teaching, North Unit, Madrid Health Service – REDISSEC, Madrid, Spain, 7Rheumatology Service, Nuestra Se ora de Candelaria University Hospital, Tenerife, Spain, 8Research Unit, Basurto University Hospital (Osakidetza), Bilbao, Spain PRM139 Jakubczyk M 2Department of Experimental & Clinical Pharmacology, Medical University of Warsaw, Warsaw, Poland PRM140 Bilbao A 9 1Research Unit, Basurto University Hospital (Osakidetza) – Health Service Research Network on Chronic Diseases (REDISSEC), Bilbao, Spain, 2Fundaci n Canaria de Investigaci n Sanitaria (FUNCANIS) – REDISSEC, Tenerife, Spain, 3Villamanta Centre, Navalcarnero Health Centre, Madrid Health Service – REDISSEC, Madrid, Spain, 4Basauri Mental Health Center (Osakidetza) – REDISSEC, Basauri, Spain, 5Uribe Kosta Mental Health Center (Osakidetza), Getxo, Spain, 6Psychiatry Service, Basurto University Hospital (Osakidetza), Bilbao, Spain, 7Servicio de Salud Mental, Direcci n General de Programas Asistenciales, Servicio Canario de la Salud, Tenerife, Spain, 8Fuenlabrada Mental Health Center, Fuenlabrada University Hospital, Madrid, Spain, 9Research Unit, Basurto University Hospital (Osakidetza), Bilbao, Spain PRM141 F5 USING REGRESSION MODELS TO ACCOMMODATE HETEROGENEITY AND ADDRESS COHORT IMBALANCE IN PARAMETRIC SURVIVAL MODELS FOR USE IN HTA Bojke C PRM142 F6 USING A "LANDMARK" APPROACH TO ARTIFICIALLY POPULATE THE COMPARATOR ARM OF AN ECONOMIC MODEL USING DATA FROM A PHASE II, UNCONTROLLED TRIAL IN ADVANCED BASAL CELL CARCINOMA Loughran T Associate Medical Director for QI & Consultant Forensic Psychiatrist; East London NHS Foundation Trust; England Amar Shah leads the large organisation-wide quality improvement programme, aiming to embed continuous improvement within daily work at all levels of the organisation, to support the organisation to achieve its mission of providing the highest quality mental health and community care in England.

Downloadable templates staff imperial college london

Dr Shah is a Consultant forensic psychiatrist and works clinically part-time in addition to his quality leadership role.

He has degrees in healthcare management, mental health law and medical education, and has previously worked as clinical advisor at the National Patient Safety Agency.He is an IHI improvement advisor and faculty 1Amgen (Europe) GmbH, Zug, Switzerland, 2University of Sheffield, Sheffield, UK, 3University of York, Heslington, York, UK, 4Albert Einstein College of   IDENTIFYING COST EFFECTIVE METHODS OF HEALTH TECHNOLOGY ASSESSMENT FOR DEVELOPERS – THE NEED FOR FAST AND FRUGAL EVALUATION.He is an IHI improvement advisor and faculty.

He has authored a number of peer-review articles and book chapters on the topic of safety and quality improvement, and is a regular presenter at regional, national and international conferences on quality improvement.Director, Patient Safety and Europe, Institute for Healthcare Improvement (IHI) Amelia Brooks has expertise in quality improvement, patient safety, human factors, analytics for improvement, and safety culture This brief guide to the writing and presentation of essays applies to all discursive written work set in the Department of Classics, whether for assessment (i.e. counting towards the overall   For non-assessed essays, only one copy should be submitted; no coversheet is needed, but write your name clearly on the essay..Director, Patient Safety and Europe, Institute for Healthcare Improvement (IHI) Amelia Brooks has expertise in quality improvement, patient safety, human factors, analytics for improvement, and safety culture.Amelia joined IHI in January 2016 as a Director in the Patient Safety Team, where her role includes teaching, diagnostics, and onsite coaching for organisations.

She is also now IHI’s Regional Director for the Europe Region and lives in the UK.Amelia leads a number of IHI’s European programs and oversees all regional activity.Prior to joining IHI, Amelia worked in strategic and operational roles in the patient safety and improvement fields, including frontline roles as a quality improvement specialist.Prior to joining IHI, she led the design, development, and implementation of a regional Patient Safety Collaborative in England.Associate Professor of Communication Science, Universit della Svizzera italiana (University of Lugano); Switzerland Annegret F.

is Associate Professor of Communication Science at the Universit della Svizzera italiana (University of Lugano) in Switzerland, where she directs a Center for the Advancement of Healthcare Quality and Patient Safety (CAHQS).In 2013, she founded the ISCOME Global Institute for the Advancement of Communication in Healthcare, which pursues interdisciplinary research collaborations between communication science and healthcare.

In 2016, she received the Jozien Bensing Research Award for outstanding career achievements and impact.

Her empirical research has been published in a variety of distinguished international journals and books.CMO, Quality Management (QM) Program in the Ministry of Health and Social Services (MoHSS); Namibia Dr.Apollo Basenero, MBChB, has worked as a medical doctor in Uganda, Eritrea and Namibia.He is currently the Chief Medical Officer, Quality Management (QM) Program in the Ministry of Health and Social Services (MoHSS) Namibia.He is a Fellow, International Society for Quality in Health Care (ISQua) and Fellow, Arthur Ashe Endowment for the Defeat of AIDS.

His achievements include leading the teams that developed the following; Generic MoHSS National QM training curricula for healthcare workers, Consumer Involvement in QM curriculum, QM Coaches curriculum, QM Trainer of Trainers Program and QM capacity building framework for the MoHSS.He was also part of the team that developed Namibian guidelines on; Infection Prevention and Control, Operating Room, Sterile Services and Phlebotomy.He is one of the Quality Improvement (QI) leaders in an ongoing QI Collaborative in Namibia that is focused on improving retention in HIV Care.He has participated in various research projects, authored and co-authored a number of abstracts, serves on various QM committees and has won a few professional awards.Basenero is very passionate about implementation of continuous quality improvement in healthcare.Associate Professor, HAN University; The Netherlands Bauke trained as RN (1997), community psychiatric nurse (2000), and advanced nurse specialist (2005).He obtained his PhD in social sciences in 2011, following a number of studies into so-called ‘difficult patients’ in mental health services.He earned a Master degree in epidemiology in 2010 and became Associate Professor at the HAN University in 2011.Since, he has been working on system-wide improvement of services for people with severe mental disorders, hoping to achieve better outcomes for services users and society as a whole.

His work with Dutch police accelerated after the 2017 publication of a book on mental disorders and health services from a public health service.Associate Medical Director (Quality Improvement) & Consultant Paediatrician, Imperial College Healthcare NHS Trust; UK Dr Klaber is a Consultant General Paediatrician who also trained as an educationalist alongside his postgraduate paediatric training in London.

Should i purchase an healthcare presentation no plagiarism a4 (british/european) premium american double spaced

Bob has a strong interest in learning and leadership development and set up the Paired Learning programme, which has now been adopted by a number of organisations across the UK.Through his Associate Medical Director role Bob is now leading an ambitious project to develop a values-based quality improvement programme across Imperial.Bob is also a strong advocate for child health and co-leads the Connecting Care for Children (CC4C) integrated child health programme in North West London Please click on the operating system links below for access to downloadable templates for agendas, badges, letters, minutes and PPT presentations. Some templates are intended for use with the pre-printed College stationery which is available to order via Office Depot – see the Bespoke Stationery items pdf on that page..

Bob is also a strong advocate for child health and co-leads the Connecting Care for Children (CC4C) integrated child health programme in North West London.

Medical Director, NYSDOH AIDS Institute; USA Bruce Agins, MD, MPH, Medical Director, NYSDOH AIDS Institute, oversees a staff of 40 involved in HIV treatment guidelines, quality management and education programs.He is principal architect of NY’s HIV Quality Program and has 20+ years of HIV-specific QI experience.He has participated as faculty in national HIV QI collaboratives, and chaired the faculty of the national HIV QI Collaborative for state HIV agencies Be it tending to victims of the Boxing Day tsunami, ensuring humanistic care for the homeless, or working with Wikipedia to get better health information to millions around the   You will have postgraduate training in an appropriate field to at least Masters level, including epidemiology, public health and medical specialities..He has participated as faculty in national HIV QI collaboratives, and chaired the faculty of the national HIV QI Collaborative for state HIV agencies.Agins has extensive experience in global QI and is Director for HEALTHQUAL.

Agins holds academic appointments as Professor in Global Health Sciences at UCSF and as Adjunct at NYU School of Medicine.Executive Director, Institute for Healthcare Improvement (IHI); USA Carly Strang, MBA, Executive Director, Institute for Healthcare Improvement (IHI), is the strategic and operational lead for IHI’s virtual educational trainings and programs.In partnership with the Executive Director of Events, Ms.Strang is responsible for leading a cross-functional program development team to design and deliver world-class educational programs.

Strang provides strategic planning and programmatic leadership for the IHI Open School, an initiative to build improvement capability and leadership in the next generation of health care professionals.She has organizational development experience designing an internal leadership program for middle managers, managing IHI’s internship development program, and leading cross-functional teams in internal improvement efforts.She earned her undergraduate degree in Business Administration from Northeastern University and her MBA with a Healthcare Administration concentration from Suffolk University.Cat Chatfield Quality Improvement Editor, The BMJ; UK Cat is the Quality Improvement Editor for the BMJ (previously the British Medical Journal), working in partnership with the Health Foundation to publish articles supporting clinicians to improve healthcare.

Cat was previously the Editor of BMJ Quality Improvement Reports.She has created resources, run programmes and mentored teams to help clinicians capture, publish and share their improvement journeys.Subbe Honorary Senior Clinical Lecturer and Consultant Physician, Bangor.Improvement Science Fellow, The Health Foundation, London; UK Speaker bio to follow shortly.PhD Candidate Health Care Governance Erasmus School of Health Policy & Management; The Netherlands David de Kam is a PhD candidate at the Health Care Governance Group, Erasmus School of Health Policy & Management in Rotterdam.He holds degrees in Literature and Healthcare Management.De Kam’s PhD research project studies how the governance of quality and safety of care comes about through the interactions between (external) regulation and supervision, how healthcare organizations address quality and safety—as well as the regulatory demands they face—and how healthcare professionals ‘do’ quality and safety.David Williams Executive Director & Improvement Advisor, Institute for Healthcare Improvement (IHI); USA David Williams, Executive Director, Institute for Healthcare improvement (IHI), is co-lead of Improvement Capability at IHI and a senior improvement advisor.

He has served as the Improvement Advisor for large Breakthrough Series Collaboratives in the United States and Europe.Williams is faculty for the IHI Improvement Advisor Professional Development Program, IHI Open School, and the Massive Open Online Course (MOOC) developed in collaboration with HarvardX.A paramedic by background, he is internationally known as an expert on paramedic care and emergency medical services systems.

Fun Fact: He is creator of the Mr Potato Head PDSA exercise.

President and CEO, Institute for Healthcare Improvement; USA Derek Feeley joined IHI as Executive Vice President in September 2013.At IHI, Derek has executive level responsibility for driving IHI’s strategy across five core focus areas; Patient Safety; Patient and Family Centred Care; Quality, Cost and Value; Population Health; and Improvement Capability.His work is international in scope, guiding work to deliver IHI’s mission to improve health and care across the world.

Best website to purchase a college healthcare presentation 100% original mla 5 days premium custom writing

Prior to taking up his current role, Derek had been Director General (DG) Health and Chief Executive of the National Health Service (NHS) in Scotland since November 2010.From January 2011, the DG role was extended to cover Health and Social Care.

He was the principal adviser to Scottish Ministers on health and care issues and he provided direction to the work of NHS Boards in ensuring the delivery of high quality health and healthcare ISPOR 20th Annual European Congress Poster Presentations.He was the principal adviser to Scottish Ministers on health and care issues and he provided direction to the work of NHS Boards in ensuring the delivery of high quality health and healthcare.

Derek has had a varied background in policy analysis during thirty years in public service .From 2002 to 2004, he spent two years as Principal Private Secretary to Scotland’s First Minister International Forum on Quality and Safety in Healthcare Asia nbsp.From 2002 to 2004, he spent two years as Principal Private Secretary to Scotland’s First Minister.Thereafter, Derek moved on to work on developing a framework for service redesign in the NHS International Forum on Quality and Safety in Healthcare Asia nbsp.Thereafter, Derek moved on to work on developing a framework for service redesign in the NHS.He was a 2005-06 Harkness/ Health Foundation Fellow in Health Care Policy and spent a year in the United States working with Kaiser Permanente and the Veteran’s Health Administration.

Derek was appointed as Director of Healthcare Policy and Strategy on his return.In that role he was responsible for advising the Scottish Government on all healthcare quality issues, including patient safety, and he also led on healthcare information technology.In 2013, Derek was made a Companion of the Order of the Bath in Her Majesty the Queen’s New Year’s Honours List, in recognition of his contribution to healthcare.He was also awarded a Doctorate in Business Administration from the University of Strathclyde and a Companionship of the Institute of Healthcare Management, also in recognition of his contribution to health and healthcare.Senior Improvement Fellow, The Heath Foundation; England Dominique is a Senior Improvement Fellow at the Heath Foundation working on the Q initiative.

She also works part time in a hospital supporting more effective involvement of patients and the public in health, care and improvement Dominique has been working as a doctor in the NHS for 13 years and qualified as Consultant in Public Health Medicine in 2015.She is passionate about involving patients, carers and the public in all aspects of health and health care and her other interests include population health, quality improvement and clinical leadership and development.Dominique was named one of HSJ’s Rising Stars in 2015.Chief Scientific Officer Emeritus and Senior Fellow, Institute for Healthcare Improvement (IHI); USA Don Goldmann, MD, Chief Scientific Officer Emeritus and Senior Fellow, Institute for Healthcare Improvement (IHI), works both internally and externally to deepen IHI’s profile, credibility, and influence in improvement science and related disciplines.He seeks to expand the boundaries of improvement science by incorporating methods from other sciences, such as epidemiology, behavioral sciences, qualitative and ethnographic research, network science, and systems engineering and dynamics.

An essential part of his work is to harvest expertise, knowledge, and innovation from the field while forging relationships with key scientific, academic, health services research, and professional organizations and communities.Internally, he works with IHI colleagues, especially the Results and Evaluation Team, to ensure the rigor of IHI’s results-oriented work, and to disseminate these results in presentations at national meetings and in peer-reviewed publications.In addition, he explores new ways to teach and learn and brings best educational practices and innovations to in person and distance learning programs.Dr, Goldmann is lead faculty for the Massive Open Online Course (MOOC) developed in collaboration with HarvardX and the Harvard T.

Chan School of Public Health and works closely with IHI’s Open School program.He also serves as senior mentor for IHI’s Fellowship Programs and continues to train and mentor emerging investigators at Harvard Medical School, Boston Children’s Hospital, and the Harvard School of Public Health.He is the lead created and leads a Harvard College General Education course that explores how global infectious disease challenges often lead to social injustice.He explores the intersection of improvement science, innovation and technology, with the goal of accelerating progress towards equity and population health.

Goldmann serves on the AHRQ NAC, the Board of AcademyHealth, and the Board of the Institute for Medicaid Innovation.Emergency Physician, Sunshine Coast Hospital and Health Service, Queensland; Australia Dr Elizabeth Marsden (MBBS, FACEM) – an Emergency Physician with a passion for the care of the elderly in the Emergency Department.She is the innovator and driver of the Geriatric Emergency Department Intervention (GEDI) service.Dr Marsden worked closely with a research team from the University of the Sunshine Coast to acquire competitive grant funding to trial the GEDI model of care.

She is completing a PhD evaluating the outcomes for residents of Aged Care Facilities in the ED since inception of GEDI in the Sunshine Coast Hospital and Health Service.

Speakers international forum on quality and safety in healthcare

Her other research interests include geriatric trauma.Project Coordinator, Netherlands Federation of University Medical Centres – Consortium Quality of Care Erica De Loos, MSc, FISQua, Change Agent has been working on European, global and national quality improvement programmes in hospitals in collaboration with international stakeholders since 2005.Such as the WHO High 5s programme (9 countries), the European project for Patient Safety and Quality of Care (28 Member States) and the national Better Faster programme How to purchase a college healthcare presentation cheap double spaced Undergraduate Turabian British.Such as the WHO High 5s programme (9 countries), the European project for Patient Safety and Quality of Care (28 Member States) and the national Better Faster programme.

After home care nursing she has been working for CBO Dutch Institute for Healthcare Improvement for 10 years.

In 2015 she worked for the national Institute for Accreditation in Healthcare Where to buy a civil engineering research paper american formatting nbsp.In 2015 she worked for the national Institute for Accreditation in Healthcare.Since 2016 she works for the Netherlands Federation of University Medical Centres – Quality of Care Where to buy a civil engineering research paper american formatting nbsp.Since 2016 she works for the Netherlands Federation of University Medical Centres – Quality of Care.Director Clinical Governance, ADK Hospital; Maldives As Director Clinical Governance, Dr Faisal Saeed is leading the quality improvement, patient safety and risk management mechanism at ADK Hospital myerscleaning.com/coursework/chemistry.php.Director Clinical Governance, ADK Hospital; Maldives As Director Clinical Governance, Dr Faisal Saeed is leading the quality improvement, patient safety and risk management mechanism at ADK Hospital.Since his pledge to “spark a revolution in the Maldives healthcare system” made at the International Forum on Quality and Safety in Paris, he underwent a bespoke programme on patient safety provided by Healthcare Improvement Scotland, spent time as a visiting researcher at the Centre for Quality in Denmark, and worked at the Agency for Clinical Innovation in NSW, Australia as an Endeavour Executive Fellow chemistry.Since his pledge to “spark a revolution in the Maldives healthcare system” made at the International Forum on Quality and Safety in Paris, he underwent a bespoke programme on patient safety provided by Healthcare Improvement Scotland, spent time as a visiting researcher at the Centre for Quality in Denmark, and worked at the Agency for Clinical Innovation in NSW, Australia as an Endeavour Executive Fellow.He is an NHS Certificated Change Agent, and also a Fellow of the International Society for Quality in Healthcare.

Dean, Royal Society of Medicine & Founder Editor BMJ Quality and Safety; UK Fiona Moss is the Director of Medical and Dental Education Commissioning for London.She is the editor of the Postgraduate Medical Journal, a member of the Royal Society of Medicine Press Board and sits on the Editorial Board of the BMJ.In 2006 Fiona was awarded a CBE for services to medicine.Fiona became one of London’s Postgraduate Deans in 2004 before accepting the position of Director in May 2010.

Whilst at the Deanery, Fiona has established London’s Specialty Schools and in 2009, with NHS London she set up the Darzi Fellowship Programme.

Between 1991 and 2006 Fiona was a Consultant Respiratory Physician at Central Middlesex Hospital in addition to being an Associate Postgraduate Dean for London.During this time she was also Director of Clinical Studies (DCS) for undergraduate medical students at Central Middlesex and chaired the Imperial College DCS committee.Vice President and Senior Safety Expert, Institute for Healthcare Improvement (IHI); USA Frank Federico, R.is Vice President and Senior Safety Expert, Institute for Healthcare Improvement in Cambridge, MA.

His primary areas of focus include patient safety and application of reliability principles in health care.He is also faculty for the Patient Safety Executive Development Program.He is Chair of the National Coordinating Council for Medication Error Reporting and Prevention (NNC MERP), and Vice-Chair of the Joint Commission Patient Safety Advisory Group.Frank Federico is co-author of the IHI White Paper Respectful and Effective Crisis Management, and contributing author to Achieving Safe and Reliable Healthcare, Strategies and Solutions.He has authored several articles focusing on patient safety.

Frank Federico coaches teams and lectures extensively nationally and internationally.Chairman and CEO, Virginia Mason Health System; USA Dr.Kaplan’s leadership at Virginia Mason has been recognized by the Harvard Business School as a standard-setting approach to improving cost and quality; he is widely recognized as one of the most influential physician executives in health care.He has developed and led national “market-place collaboratives” with key employers to reduce health costs and dramatically improve both employee productivity and corporate competitiveness.G ran Henriks Chair Emeritus, International Forum Programme Advisory Committee and Chief Executive of Learning and Innovation, J nk ping County Council; Sweden G ran Henriks is Chief Executive of Learning and Innovation at the Qulturum in the County Council of J nk ping, Sweden.

The Qulturum is a centre for quality, leadership and management development for the employees in the County and also for the health care on the regional and national level.G ran took up his appointment in the start of Qulturum 1998.

Best website to get college presentation healthcare rewriting business 48 hours premium

He has over twenty year’s experience of management in the Swedish health care system.G ran is a member of the J nk ping County Council Strategic Group.G ran has been J nk ping’s project director for the Pursuing Perfection initiative over the last four years and is a senior fellow of the Institute for Healthcare Improvement, Cambridge, MA 19 Nov 2013 - Keynote presentation, European Commission, EUNEC (European Network of Education   A College of Dublin City University. Ireland   process and needs systematic expression at a range of earlier stages as part of a Europe-wide prevention focus (Downes 2013). A4. Overcoming System Blockages in..

G ran has been J nk ping’s project director for the Pursuing Perfection initiative over the last four years and is a senior fellow of the Institute for Healthcare Improvement, Cambridge, MA.

In addition, he is part of the Strategic Committee of the International Quality Forum organised by the British Medical Journal (BMJ) and the Institute for Healthcare Improvement.Chief Transformation Officer, NHS Horizons; England Helen Bevan is acknowledged globally for her expertise and energy for large scale change in health and care .Chief Transformation Officer, NHS Horizons; England Helen Bevan is acknowledged globally for her expertise and energy for large scale change in health and care.During her 25 years as a change leader in the English National Health Service, Helen has been at the forefront of many NHS improvement initiatives that have made a difference for thousands of patients and for the staff who care for them.Helen currently leads the Horizons team, which is a source of ideas and knowledge to enable the spread of improvements at scale.The team uses a variety of different tools and approaches including social movement thinking, community organising, improvement science, accelerated design and digital connectivity.

It champions the role of emerging leaders, students and trainees at the forefront of radical change.Associate Professor of Medical Education, Maastricht University; The Netherlands Jamiu Busari, is an associate professor of medical education at Maastricht University and a consultant Paediatrician, Department chair and program director of the Paediatric residency program at Zuyderland Medical Centre Heerlen, the Netherlands.Jamiu has a wealth of (inter)national experience in the fields of postgraduate training, curriculum development, quality assurance and quality improvement in health care delivery, having trained and worked in Africa, the Caribbean, Europe and North America.His current areas of research include investigating, designing and developing innovative strategies for managerial and leadership competency development in junior physicians.Director of the Institute for Healthcare Improvement’s Open School; USA Jessica Perlo, MPH, Director of the Institute for Healthcare Improvement’s Open School, a global interprofessional community that provides health students and professionals with the skills to become change agents in health care.

Jessica holds a Bachelors in Science from the University of Vermont and a Masters in Public Health from Boston University School of Public Health.She is trained in community organizing from the Harvard Kennedy School of Government and facilitative leadership from the Interaction Institute for Social Change.For over ten years she’s worked in health professional program development and quality improvement at both Harvard’s Academic Medical Centers and at IHI.Jessica leads IHI’s effort to mobilize students to take action to improve the health of populations and achieve the Triple Aim.She is also a member of the Leadership Team of 100 Million Healthier Lives, a health equity social movement convened by IHI, and serves as the Director of IHI’s Joy in Work Portfolio.

Quality and Safety Improvement Manager, Cardiff and Vale University Health Board; Wales Joy has a rare combination of experience incorporating nursing and improvement roles across the healthcare community from Primary Care to tertiary services.The past 16 years have been as a leader of improvement.Joy was seconded to the all-Wales 1000 Lives Campaign where she worked nationally as an Improvement Advisor.Currently she is Quality and Safety Improvement Manager in one of the largest healthcare organizations in the UK and is an Executive Coach.She has a part time secondment to the Wales Deanery to support the integration of QI skills into post graduate specialty doctor and dentist training.

Medical Director, Head & Heart Center, Aarhus University Hospital; Denmark Kirsten Wisborg is trained in paediatrics and neoantalogy, primarily in Denmark but also in Norway and the UK.She holds a doctoral degree in medicine from Aarhus University and a master degree in public management from the University of Southern Denmark.From 2011-2013 she was head of Department of Paediatrics at Randers Regional Hospital, Denmark and from 2013-2017 Centre Director at Head and Heart Centre, Aarhus University Hospital.From 2017 she is medical director at Bispebjerg and Frederiksberg Hospital (BFH).Bispebjerg and Frederiksberg Hospital is a university hospital with main fokus on tertiary and emergency care in close combination with teaching and research.

It serves 455,000 citizens and has 4200 employees.Kristen Will Director, Health Solutions Executive Education, Clinical Assistant, Professor, Science of Health Care Delivery, College of Health, Solutions, ASU; USA Ms.

Best website to buy a healthcare presentation american standard double spaced academic

Will serves as the Director of Executive Education in the College of Health Solutions and as Clinical Assistant Professor in the School for the Science of Health Care Delivery.Will practiced as a hospitalist PA at Mayo Clinic Hospital in Arizona for 15 years.

Leader of Quality, Safety and Accreditation, BC Children’s Hospital, Vancouver; Canada Liz Lamb is a leader of quality, safety and accreditation at BC Children’s hospital in Vancouver, Canada Cochrane News Cochrane Neonatal.Leader of Quality, Safety and Accreditation, BC Children’s Hospital, Vancouver; Canada Liz Lamb is a leader of quality, safety and accreditation at BC Children’s hospital in Vancouver, Canada.

Her passion for innovation combined with her experience in paediatric nursing and quality improvement led her to champion a pilot project using design thinking methodology to co-design a better way to prepare children and families for surgery.Her career spans the UK and Canada and previous roles include leader of innovation and engagement at the BC Patient Safety Quality Council, improvement coach with the child youth mental health substance use collaborative, and quality improvement advisor for Doctors of BC.Director, Institute for Healthcare Improvement (IHI)’s Innovation Team; USA Mara Laderman, MSPH, is a Director with the Institute for Healthcare Improvement (IHI)’s Innovation Team 28 Sep 2015 - in Healthcare. 12-15 April 2016 | Gothenburg, Sweden. 4 day event. 200+ international speakers. 3,000 attendees. 100+ sessions and presentations   Get connected at the Forum! Join the conversation on Twitter! #quality2015. @QualityForum. All you need is an internet connection and a Twitter account..Director, Institute for Healthcare Improvement (IHI)’s Innovation Team; USA Mara Laderman, MSPH, is a Director with the Institute for Healthcare Improvement (IHI)’s Innovation Team.She is the content lead for IHI’s work in behavioral health, directing research initiatives and developing programming focused on better meeting individuals’ behavioral health needs across the health care system.

She also leads innovation projects on population health improvement, including recent work on the opioid crisis, health equity, and age-friendly care.Prior to IHI, she served as an external program evaluator for the Massachusetts Department of Public Health and the Centers for Disease Control and Prevention and managed a large psychiatric epidemiology study at the Center for Multicultural Mental Health Research.Laderman received a Master of Public Health from the Harvard T.Chan School of Public Health and a Bachelor of Arts in Psychology from Smith College.Senior Researcher, Health Informatics Centre, Karolinska Institutet, Stockholm; Sweden Maria H gglund is a senior researcher at the Health Informatics Centre at Karolinska Institutet in Stockholm, Sweden.Her research focuses on user-centred development of patient-centred information and communication systems to support collaboration within health- and social care as well as patient empowerment.She is a member of the DOME research consortium, and the project leader for the PACESS research project (patient-centred assessment of patients’ online access to electronic health records).Maria is also the programme director for the Joint Global Masters Programme in Health Informatics at Karolinska Institutet/Stockholm University.

Director, Celsus Academy of Sustainable Health Care; The Netherlands Marit Tanke, MD / PhD, is a 2016-17 Commonwealth Fund Harkness Fellow in Health Care Policy and Practice.She currently serves as director of the Celsus Academy of Sustainable Health Care, a collaboration of the Dutch Ministry of Health, Welfare and Sport and Radboud University Medical Center Nijmegen.Her research portfolio includes outcome measurement and value-based purchasing strategies, health policy, healthcare reform, reimbursement design, and large-scale healthcare transformations.She has also co-developed an interactive online master course on ‘value’ in health care for medical specialists and residents and a seminar on sustainable healthcare systems for the Dutch National Academy of civil servants.Founder and CEO, Patients Know Best; UK Mohammad trained as a physician at the University of Cambridge; worked as a staff scientist at the National Institutes of Health; and was a management consultant to US hospitals at The Advisory Board Company.

Mohammad is the author of seven books, including Personal health records: A guide for clinicians and Streamlining Hospital-Patient Communication: Developing High Impact Patient Portals.He is also an honorary senior research associate at UCL medical school for his research on patient-controlled medical records.In 2012 he was elected an Ashoka Fellow as a social entrepreneur for the contributions he has made to patient care.Police Sergeant, Hampshire Constabulary Mental Health Team Paul is from the Mental Health team at Hampshire Constabulary but this year is leading the establishment of a High Intensity Network through the expansion of the award-winning SIM Model of Care, (funded by the NHS Innovation Accelerator Programme).He has over 20 years lived experience of clinical depression, has been detained twice under s136 and was also arrested during the most intense period of illness in 2010, spending 14 hours in the same police cells that he used to manage as a custody sergeant.

He has dedicated the rest of his career to the advancement of mental health related policing.Head of Latin America and Europe, IHI; USA Pedro Delgado, MSc, has a unique ability to work across cultures, languages, and systems.Based in the United Kingdom, he has been a driving force in IHI’s global strategy.From work on reducing C-sections in Brazil, to improving early years education in Chile, to improving patient safety in Portugal and mental health in London, Mr.Delgado has led the key senior relationships and design and implementation of large-scale health system improvement efforts and networks globally.

Ideal backgrounds for private equity askivy

He holds summa cum laude degrees in Psychology and in Global Business, and an MSc in Healthcare Management and Leadership.Executive Director of Strategy and Improvement, Scottish Care Inspectorate; Scotland Rami Okasha is a graduate of the University of Aberdeen and Queen Margaret University, with a background in public sector leadership and policy.He the Scottish Care Inspectorate’s Executive Director of Strategy and Improvement, leading national improvement programmes, new scrutiny methodology, care intelligence, and public involvement We want to be the leading advocate for evidence-informed health care across the world. Applying: If you would like to apply for this position, please send a CV along with a supporting statement to [email protected] with “Junior Software Developer” in the subject line. The supporting statement should indicate why  .He the Scottish Care Inspectorate’s Executive Director of Strategy and Improvement, leading national improvement programmes, new scrutiny methodology, care intelligence, and public involvement.

He co-chaired the development of new national care standards across health and social care provision in Scotland, working with people who use care to ensure these are outcomes-focused, based on human rights and well-being, and person-led.He previously occupied senior roles advising political leaders and in developing educational policy A Holistic Approach to Early School Leaving Prevention in Europe nbsp.

He previously occupied senior roles advising political leaders and in developing educational policy.

Vice President, Institute for Healthcare Improvement; USA Dr.Robert Lloyd is Executive Director of Performance Improvement for the Institute for Healthcare Improvement (IHI).Lloyd provides leadership in the areas of performance improvement strategies, statistical process control methods, development of strategic dashboards and quality improvement training.He also serves as lead faculty for various IHI initiatives and demonstration projects in the US, the UK, Sweden, Denmark, New Zealand, Qatar, Dubai and Africa.

Lloyd served as the Corporate Director of Quality Resource Services for Advocate Health Care (Oak Brook, IL).He also served as Senior Director of Quality Measurement for Lutheran General Health System (Park Ridge, IL), directed the American Hospital Association’s Quality Measurement and Management Project (QMMP) and served in various leadership roles at the Hospital Association of Pennsylvania.The Pennsylvania State University awarded all three of Dr.His undergraduate degree is in sociology, his master’s degree is in regional planning and his doctorate is in rural sociology.Lloyd has addressed over 1,200 national and international meetings of professional groups and associations.Over 150,000 participants from this country and abroad have attended his classes and presentations on quality improvement.

He has served as faculty for the Harvard School of Public Health, the American College of Healthcare Executives, the American Society for Quality (ASQ), the University of Wisconsin’s graduate program in Administrative Medicine, the University of Chicago’s graduate Program in Health Administration, the Healthcare Forum, the International Quality and Productivity Center, the American Health Information Management Association, the JCAHO, the Group Practice Improvement Network, the Ontario Hospital Association, the Vancouver BC Quality Forum, the Medical Group Management Association, the BMJ European Quality Forum (London, Barcelona, Berlin, Amsterdam and Paris), and numerous QIOs around the US.

Lloyd has also presented his seminars on statistical thinking to physicians and administrators from the Federation of County Councils in Stockholm and Jonkoping, Sweden, to leaders of the National Health Service throughout the United Kingdom and New Zealand, and to patient safety leaders throughout Denmark, South Africa and Ghana.He has published numerous articles, chapters and reports on a wide range of topics including CQI theory and implementation, measurement and statistical methods, clinical outcomes, customer satisfaction, information systems and parish nursing.Lloyd is co-author of the internationally acclaimed book, Measuring Quality Improvement in Healthcare: A Guide to Statistical Process Control Applications (American Society for Quality Press, 2001, 5th printing).

His most recent book, Quality Health Care: A Guide to Developing and Using Indicators was published in March of 2004 by Jones and Bartlett (Sudbury, MA).Executive Director of Nursing, Cardiff and Vale University Health Board; Wales Ruth has undertaken leadership roles which include Chair of Nurse Directors Forum, Welsh representative on DoH Modernising Nursing Careers, Kings Fund/ Burdett Trust Ward to Board and implementation of a key national work stream.Ruth sits on a number of national groups and has a special interest in professional leadership, increasing the contribution of the professions to improving care delivery, safety and service improvement.An experienced Director of Nursing currently in her 3rd executive post, Ruth has over 30 years experience in the NHS.This experience spans primary, community, secondary and tertiary care settings.

She has had significant success in the delivery of the quality and safety agenda along with strategic leadership of the nurses and midwives.Head of the North America Region, Institute for Healthcare Improvement (IHI); USA Saranya Loehrer, MD, MPH, Head of the North America Region, Institute for Healthcare Improvement (IHI), leads a team responsible for the development and execution of regional priorities in service of achieving IHI’s mission.Her team works in partnership with others at IHI to cultivate collaborative relationships, support new business development, and design large-scale initiatives that help organizations meet their aims and aspirations.Current regional efforts include accelerating the volume-to-value transformation in health care, attending to the joy of the health care workforce, and nurturing cross-sector partnerships that support the equitable achievement of health in the communities we serve.Loehrer worked for Physicians for Human Rights, leading global and domestic grassroots advocacy efforts to create more just and scientifically sound HIV/AIDS policies.She received her MD from Loyola University Chicago Stritch School of Medicine, where she was an Albert Schweitzer Fellow, and her MPH from the Harvard School of Public Health, where she was a Zuckerman Fellow.

How to order a college healthcare presentation standard high school double spaced american

Stephen Swensen is the Medical Director for Leadership and Organization Development and a Professor in the Mayo Clinic College of Medicine.From 2005-2012 he served as the Director for Quality and Associate Dean for Value.

Under his leadership, the Quality Academy and the Value Creation System were established Associate Medical Director (Quality Improvement) & Consultant Paediatrician, Imperial College Healthcare NHS Trust; UK   A graduate of Glasgow University and Harvard School of Public Health, Dr Brian Robson has a background in general practice, GP out of hours, telephone triage and latterly eHealth and Quality  .Under his leadership, the Quality Academy and the Value Creation System were established.

More than 35,000 colleagues have been certified as Bronze, Silver or Gold Quality Fellows.Swensen has been conferred the Diamond Quality Fellow Lifetime Achievement Award.Swensen chaired the Department of Radiology from 1998-2006 Help me do an presentation healthcare Premium Writing from scratch one hour A4 (British/European).Swensen chaired the Department of Radiology from 1998-2006.His leadership team used Lean-Sigma and Baldrige methods to improve the value of care for patients provided by 1,200 staff who performed more than one million exams annually.During his tenure the department was recognized as the No.1 radiology practice in the USA (Medical Imaging) and the most Patient-Centered (Diagnostic Imaging).Swensen has served as a Director on three Boards and as a member of the Mayo Clinic Management Team and Clinical Practice Committee.He holds a Masters of Medical Management from Carnegie Mellon University’s Heinz School.He received his MD from the University of Wisconsin.

His residency training was at the Mayo Clinic and his Thoracic Radiology Fellowship at Harvard Medical School, Brigham and Women’s Hospital.Swensen is a Senior Fellow of the Institute for Healthcare Improvement.He is past President of two international societies, the Fleischner Society and the Society of Thoracic Radiology.He teaches Value Creation at the School of Public Health in the University of Minnesota.

He chaired the American College of Radiology’s Quality Metrics Committee and led the RSNA’s Continuous Quality Improvement Initiative.He founded the Big Sky Quality Roundtable, and the Keystone Quality Officer Group, and co-founded the Sun Valley Quality Assembly.

He has been Principal Investigator of three NIH grants related to lung cancer screening with CT and diffuse infiltrative lung disease.He has authored two books and more than 140 peer-reviewed articles.He has been married for 36 years and has two children.

This year he completed his 37th marathon.President, Planetree International Susan Frampton is the President of Planetree International, a non-profit advocacy and membership organization that works with a growing network of healthcare provider organizations across the continuum to implement comprehensive person-centered models of care.Frampton, a medical anthropologist, has authored numerous publications, including the three editions of Putting Patients First (Jossey-Bass 2004, 2008, 2013), and served as lead author on the National Academy of Medicine’s Harnessing Evidence and Experience to Change Culture, released in early 2017.Frampton chaired the National Academy of Medicine’s Scientific Advisory Panel on the Evidence Base for Patient-Centered Care, which led to this ground-breaking publication.